Recent searches
Search options
Administered by:
Shortages of #GLP1 medicines are growing worse. Novo Nordisk says "many patients will have difficulty filling #Saxenda prescriptions for the remainder of 2023 and beyond."
Was this foreseeable? Or is #ObesityCare for the few and the wealthy all we get?
https://conscienhealth.org/2023/07/glp-1-medicines-constrained-supply-high-prices-low-access/
ConscienHealthGLP-1 Medicines: Constrained Supply, High Prices, Low Access - ConscienHealthConstrained supply, high prices, and low access to care have a way of taking the shine off the remarkable progress of obesity medicines.